Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data

High effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and...

Full description

Bibliographic Details
Main Authors: A. E. Radzevich, A. G. Evdokimova, A. Yu. Konyakhin, V. V. Popov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
coronary heart disease
sudden cardiac death
beta-adrenoblockers
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1505
Description
Summary:High effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and sudden cardiac death risk in CHD patients.
ISSN:1728-8800
2619-0125

Similar Items